Chickens from one day old (breeders and layers).

Active immunisation of chickens to reduce colonisation, persistence and invasion of the intestinal tract and internal organs by Salmonella Enteritidis and Salmonella Typhimurium.

Onset of immunity within 6 days after first vaccination.

Duration of immunity for Salmonella Enteritidis is 35 weeks after second vaccination and 63 weeks after third vaccination when used according to the recommended vaccination schedule.

Duration of immunity for Salmonella Typhimurium is 60 weeks after the third vaccination when used according to the recommended vaccination schedule.

Do not use in broilers.

Vaccinate healthy animals only.

Vaccinated chickens excrete the vaccine strain up to six weeks following vaccination. During this time, the contact of immunosuppressed and unvaccinated chickens with vaccinated chickens should be avoided.

The vaccine can spread to susceptible birds. Special precautions should be taken to avoid spreading of the vaccine strain to susceptible birds. Contact chickens may also excrete the vaccine strain.

The vaccine strain has been isolated from chicken litter up to 13 days after vaccination. In studies, the vaccine strain can be found in the environment for up to 8 weeks after the 2nd vaccination and 5 weeks after the 3rd vaccination. On very rare occasions, the vaccine strain may be isolated from the environment beyond the above mentioned period.

The vaccine strain has been shown to spread to non-target species such as calves and pigs. It persisted in these animals and was excreted over a period of 9 days in calves and 22 days in pigs and has been shown to cause a transient increase in body temperature. The use of the vaccine in fancy breeds has not been studied.

The vaccine strain is among others sensitive to ampicillin, cefotaxime, chloramphenicol, ciprofloxacin, gentamycin, kanamycin, oxytetracycline, streptomycin. The vaccine strain is resistant to sulfamerazine alone but sensitive to sulfamerazine and trimethoprime in combination.

Due to the adenine-histidine auxotrophy of the vaccine strain, a differentiation between vaccine and field strains is possible by means of an appropriate growth test such as the Ceva S-check test.

A clear vaccine strain wild type strain differentiation is also possible on special chromogenic selective media (e.g. ASAPTM media, Biomérieux) due to a different colour of the vaccine colonies versus wild SE strains. The vaccine strain can also be distinguished from the field strain by molecular biology methods, such as real time Polymerase Chain Reaction (PCR) and Restriction Fragment Polymorphism (RFLP) in Pulse Gel Electrophoresis (PFGE).

Appropriate veterinary and husbandry measures should be taken to avoid spread of the vaccine strain to susceptible species.

In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician. The vaccine strain is sensitive to antibiotics with the exception of sulfamerazine.

Use disposable gloves when reconstituting the vaccine. Wash and disinfect hands after handling vaccine. Do not ingest. If the vaccine has been swallowed seek medical advice.

Immunocompromised persons are advised to avoid contact with the vaccine and vaccinated animals during the excretion of the vaccine strain. Personnel involved in attending vaccinated chickens should follow general hygiene principles (changing clothes, wearing gloves, cleaning and disinfection of boots) and take particular care in handling litter from recently vaccinated chickens. Hands should be washed and disinfected after attending vaccinated chickens.

Not applicable.

None known.

Laying birds:

Do not use in birds in lay and within 3 weeks before the start of laying period. Unvaccinated birds intended for lay should not come into contact with vaccinated birds.

No anti-infective substances should be used within 3 days before and after immunisation with the vaccine. In case of essential administration, the vaccination of the concerned birds has to be repeated.

No information is available on the safety and efficacy of this vaccine when used with any other veterinary medical product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.

No competitive microflora preparations should be administered concurrently with the product.

One dose from first day of age, a second dose two weeks later and a third dose not later than three weeks before the laying period. There should be more than two weeks between the second and third administration.

One dose from first day of age followed by a second dose two weeks later (but not later than 6 weeks before the onset of lay). A greater level of protection, with regards to the duration of immunity, is observed with the 3-dose regime.

One dose from first day of age, a second dose six weeks later and a third dose around 13 weeks of age.

Administration in drinking water (oral route).

Birds may have drinking water withdrawn for 1-2 hours before administering vaccine.

As a guide, administer the vaccine in a volume of at least 2 litres of drinking water per 1,000 chickens at first vaccination and at least 5 litres of drinking water per 1,000 chickens at second vaccination two weeks later.

If a third dose is administered, use at least 10 – 20 litres of drinking water per 1,000 chickens. This third dose should be administered not later than three weeks before the laying period.

Administration of an overdose (10 doses) can occasionally result in loose faeces and in a transient weight loss without any consequences on the final performances.

Meat: 6 weeks from last vaccination.

Eggs: 3 weeks after third vaccination

Do not use within 3 weeks before the start of the laying period.